Salbutamol or mist in acute bronchiolitis.

The role of bronchodilators in the treatment of bronchiolitis remains controversial.
A double-blind, placebo controlled trial was performed to evaluate the clinical response to nebulized salbutamol. One hundred and fifty-six infants aged between 7 weeks and 24 months who had had an episode of wheezing and other signs and symptoms of bronchiolitis were randomized to three groups as follows: (i) nebulized salbutamol was administered to 52 patients in group I at a dose of 0.15 mg/kg in 2 mL saline; (ii) saline was nebulized to 52 patients in group II and (iii) in group III 52 patients received mist in a tent. All three groups were administered oxygen during the procedures. Treatment was repeated with the same agent after 30 min if the respiratory score was 5 or more. Respiratory rate, heart rate, oxygen saturation and presence of cyanosis, wheezing, retractions were recorded before and after each treatment.
The decrease in the respiratory score was 5.2 +/- 1.8, 0.82 +/- 2.4 and 1.7 +/- 1.3 in group I, II and III, respectively. The decrease in group I was significantly higher than in the other groups. Heart rate was similar between groups. Oxygen saturation decreased in group I without reaching statistical significance.
Salbutamol was shown to be effective and safe in the treatment of acute bronchiolitis.
AuthorsD Can, G Inan, G Yendur, R Oral, I Günay
JournalActa paediatrica Japonica; Overseas edition (Acta Paediatr Jpn) Vol. 40 Issue 3 Pg. 252-5 (Jun 1998) ISSN: 0374-5600 [Print] AUSTRALIA
PMID9695300 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Bronchodilator Agents
  • Albuterol
  • Albuterol (therapeutic use)
  • Analysis of Variance
  • Bronchiolitis (drug therapy)
  • Bronchodilator Agents (therapeutic use)
  • Double-Blind Method
  • Female
  • Humans
  • Infant
  • Male
  • Respiratory Therapy (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: